These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18222440)

  • 1. A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study.
    Nielsen HS; Andersen AM; Kolte AM; Christiansen OB
    Fertil Steril; 2008 Apr; 89(4):907-11. PubMed ID: 18222440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.
    Nielsen HS; Steffensen R; Varming K; Van Halteren AG; Spierings E; Ryder LP; Goulmy E; Christiansen OB
    Hum Mol Genet; 2009 May; 18(9):1684-91. PubMed ID: 19223392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage.
    Nielsen HS; Steffensen R; Lund M; Egestad L; Mortensen LH; Andersen AM; Lidegaard Ø; Christiansen OB
    Hum Reprod; 2010 Jun; 25(6):1543-52. PubMed ID: 20395221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses.
    Christiansen OB; Steffensen R; Nielsen HS
    J Reprod Immunol; 2010 May; 85(1):9-14. PubMed ID: 20307907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HY responses in pregnancy disorders.
    Christiansen OB; Steffensen R; Nielsen HS
    Am J Reprod Immunol; 2011 Jul; 66 Suppl 1():93-100. PubMed ID: 21726344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary recurrent miscarriage and H-Y immunity.
    Nielsen HS
    Hum Reprod Update; 2011; 17(4):558-74. PubMed ID: 21482560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary recurrent miscarriage is associated with previous male birth.
    Ooi PV; Russell N; O'Donoghue K
    J Reprod Immunol; 2011 Jan; 88(1):38-41. PubMed ID: 21129780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the sex of first child on the prognosis in secondary recurrent miscarriage.
    Christiansen OB; Pedersen B; Nielsen HS; Nybo Andersen AM
    Hum Reprod; 2004 Dec; 19(12):2946-51. PubMed ID: 15513982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth.
    Nielsen HS; Witvliet MD; Steffensen R; Haasnoot GW; Goulmy E; Christiansen OB; Claas F
    J Reprod Immunol; 2010 Dec; 87(1-2):67-73. PubMed ID: 20605049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?
    Lund M; Kamper-Jørgensen M; Nielsen HS; Lidegaard Ø; Andersen AM; Christiansen OB
    Obstet Gynecol; 2012 Jan; 119(1):37-43. PubMed ID: 22183209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients.
    Christiansen OB; Kolte AM; Dahl M; Larsen EC; Steffensen R; Nielsen HS; Hviid TV
    Hum Immunol; 2012 Jul; 73(7):699-705. PubMed ID: 22537754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
    Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
    Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental karyotype and subsequent live births in recurrent miscarriage.
    Carp H; Feldman B; Oelsner G; Schiff E
    Fertil Steril; 2004 May; 81(5):1296-301. PubMed ID: 15136093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and risk of miscarriage in women with recurrent miscarriage.
    Metwally M; Saravelos SH; Ledger WL; Li TC
    Fertil Steril; 2010 Jun; 94(1):290-5. PubMed ID: 19439294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal HY-restricting HLA class II alleles are associated with poor long-term outcome in recurrent pregnancy loss after a boy.
    Kolte AM; Steffensen R; Christiansen OB; Nielsen HS
    Am J Reprod Immunol; 2016 Nov; 76(5):400-405. PubMed ID: 27600856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
    Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
    Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant.
    Nielsen HS; Christiansen OB
    Hum Reprod; 2005 Jun; 20(6):1720-8. PubMed ID: 15774545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent miscarriage: Are three miscarriages one too many? Analysis of a Scottish population-based database of 151,021 pregnancies.
    Bhattacharya S; Townend J; Bhattacharya S
    Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):24-7. PubMed ID: 20207064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal carriage of H-Y restricting HLA class II alleles is a negative prognostic factor for women with recurrent pregnancy loss after birth of a boy.
    Nørgaard-Pedersen C; Steffensen R; Kesmodel US; Christiansen OB
    J Reprod Immunol; 2023 Mar; 156():103817. PubMed ID: 36753935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.